RPXIX vs. BPTH

In the year-to-date period, RPXIX achieves a 22.95% return, which is significantly higher than BPTH's -91.49% return. Over the past 10 years, RPXIX has outperformed BPTH with an annualized return of 4.79%, while BPTH has yielded a comparatively lower -61.38% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for RiverPark Large Growth Fund (RPXIX) and Bio-Path Holdings, Inc. (BPTH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current RPXIX Sharpe Ratio is 2.07, which is higher than the BPTH Sharpe Ratio of -0.76. The chart below compares the historical Sharpe Ratios of RPXIX and BPTH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither RPXIX nor BPTH has paid dividends to shareholders.

The maximum RPXIX drawdown since its inception was -59.98%, smaller than the maximum BPTH drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for RPXIX and BPTH. For additional features, visit the drawdowns tool.

The current volatility for RiverPark Large Growth Fund (RPXIX) is 4.34%, while Bio-Path Holdings, Inc. (BPTH) has a volatility of 24.20%. This indicates that RPXIX experiences smaller price fluctuations and is considered to be less risky than BPTH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.